Synergy has a new indication for its gastrointestinal med Trulance, and to celebrate, it’s bringing its contract sales force on full time. Two hundred reps from Publicis Touchpoint will join the New ...
NEW YORK--(BUSINESS WIRE)--Synergy Pharmaceuticals Inc. (NASDAQ:SGYP), a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies, today ...
NEW YORK--(BUSINESS WIRE)--Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) today announced positive top-line results from the first of two pivotal phase 3 clinical trials evaluating the efficacy and safety ...
After conquering grocery, SYNERGY founder GT Dave tells us why he has big plans with a smaller-sized bottle for the convenience channel. A: Kombucha is a naturally sparkling, fermented tea that is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback